Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abdominal, abnormal, acute, advice, AEs, AG, aggravated, anorexia, antihypertensive, appeal, arbitration, arm, article, assumption, atrial, attention, awaiting, bacteremia, bacteria, baseline, befall, belief, Benchmark, body, broader, Cantor, carcinoid, cardiac, cardiovascular, categorized, catheter, chest, circulating, cited, cohort, coli, commentary, commonly, compassionate, competitor, complaining, complaint, confusion, contest, contesting, convene, convened, convening, convertible, correlate, CRL, CRSP, CTC, CV, death, deep, dehydration, dichloride, died, dismissing, displayed, dosimetry, doubtful, durable, dyspnea, ECG, embolism, endpoint, EPLND, estate, exhausted, fatigue, febrile, ferrante, fever, fibrillation, finite, Fitzgerald, formal, frequent, Fuji, gland, headache, hearing, hematologic, hematuria, heretofore, Highland, hospitalized, hypoxia, ICB, Inborn, indefinite, infarction, INR, intangible, intubated, Journal, karen, kishbauch, kit, lab, laxated, leukopenia, leverage, lived, MACE, magnitude, mCRPC, Memorial, merit, mg, michael, mild, motion, MRI, muscle, myelodysplastic, myocardial, naive, Naldemedine, Naloxegol, nausea, neuroendocrine, neuropathy, neutropenia, neutropenic, Nuclear, OfferingSM, OMX, Onalta, Orange, outlicensed, overallotment, pancreatic, PFO, pneumonia, policing, postponed, proceeding, proportion, Protocol, protracted, published, pulmonary, quantitative, radiolabeled, radiopharmaceutical, rash, reaction, reassessed, RECIST, refractory, renal, replacement, replacing, resolved, respiratory, resuming, revealed, revert, RFBM, RP, Scherrer, septic, Shionogi, shock, simplified, site, SPA, statistically, Strep, subcontracting, Subsector, substitute, succeeding, suggested, superseded, suspected, tablet, tabular, tachycardia, Tangible, Tasmania, thereto, TR, trofolastat, tunnel, uncollectable, uncontrolled, underwriter, unilaterally, vein, ventilator, vigorously, vomiting, week, weekly, Xofigo, Zurich
Removed:
AHP, barrier, began, binding, briner, budgetary, capacity, carryback, cell, cliff, collected, concentrated, consultation, Deposit, earning, ending, goff, guaranteed, half, HIV, internalizing, kurt, neovasculature, occupy, pen, perpetual, Pfizer, phosphoinositide, Plant, predominantly, qualifying, recovered, refund, registering, repurchase, sector, solid, source, spend, stephen, studied, surface, undergoing, undiscounted, Union, unresolved, updated
Filing tables
Filing exhibits
- 10-K Annual report
- 12.1 Exhibit 12.1 Ratio
- 21.1 Exhibit 21.1 Subsidiaries of Progenics Pharmaceuticals, Inc.
- 23.1 Exhibit 23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 Exhibit 23.2 Consent of Ernst & Young LLP
- 31.1 Exhibit 31.1 Certification
- 31.2 Exhibit 31.2 Certification
- 32.1 Exhibit 32.1 Certification
- 32.2 Exhibit 32.2 Certification
- 10.40 Exhibit 10.40
- Download Excel data file
- View Excel data file
Related press release
PGNX similar filings
Filing view
External links
Exhibit 23.1
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (Nos. 333-176244, 333-193521) and Form S-8 (Nos. 333-52277, 333-120508, 333-124910, 333-143670, 333-160389, 333-160392, 333-168124, 333-176204, 333-183511) of Progenics Pharmaceuticals, Inc. of our report dated March 15, 2012 relating to the financial statements, which appears in this Form 10‑K.
PricewaterhouseCoopers LLP
New York, New York
March 13, 2014
New York, New York
March 13, 2014